Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 62 results.
User Information
Export Records
  1. 1.   Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus - A cancer immunotherapy candidate
  2. Stern,Stephan; Affonso de Oliveira, Jessica Fernanda; Gatus, Jamie; Edmondson,Elijah; Dobrovolskaia,Marina; Steinmetz, Nicole F; Neun, Barry W
  3. Toxicology Reports. 2025, Jun; 14: 102022.
  1. 2.   Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  2. Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman, Kelley; Hrones, Donna Mabry; Wang, Sophie; Hernandez, Jonathan M; Wood, Bradford J; Levy, Elliot B; Juburi, Israa; Hewitt, Stephen M; Kleiner, David E; Steinberg, Seth M; Figg, William D; Redd, Bernadette; Homan,Philip; Cam, Maggie; Ruf, Benjamin; Duffy, Austin G; Greten, Tim F
  3. Journal for Immunotherapy of Cancer. 2023, Feb; 11(2):
  1. 3.   Adaptation of HIV-1/HIV-2 Chimeras with Defects in Genome Packaging and Viral Replication
  2. Rawson, Jonathan M O; Nikolaitchik,Olga; Yoo, Jennifer A; Somoulay, Xayathed; Brown, Matthew A; Mbuntcha Bogni, Franck S; Pathak,Vinay; Soheilian,Ferri; Slack, Ryan L; Sarafianos, Stefan G; Hu,Wei-Shau
  3. mBio. 2022, Aug 29; e0222022.
  1. 4.   Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients
  2. Dai, Lu; Lu, Yong-Chen; Chen, Jungang; Plaisance-Bonstaff, Karlie; Mu, Shengyu; Forrest, J Craig; Whitby,Denise; Post, Steven R; Qin, Zhiqiang
  3. Frontiers in Microbiology. 2022, Apr 19; 13: 882520.
  1. 5.   Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQß1
  2. Valencia, Ana; Vergara, Candelaria; Thio, Chloe L; Vince, Nicolas; Douillard, Venceslas; Grifoni, Alba; Cox, Andrea L; Johnson, Eric O; Kral, Alex H; Goedert, James J; Mangia, Alessandra; Piazzolla, Valeria; Mehta, Shruti H; Kirk, Gregory D; Kim, Arthur Y; Lauer, Georg M; Chung, Raymond T; Price, Jennifer C; Khakoo, Salim I; Alric, Laurent; Cramp, Matthew E; Donfield, Sharyne M; Edlin, Brian R; Busch, Michael P; Alexander, Graeme; Rosen, Hugo R; Murphy, Edward L; Wojcik, Genevieve L; Carrington,Mary; Gourraud, Pierre-Antoine; Sette, Alessandro; Thomas, David L; Duggal, Priya
  3. American journal of human genetics. 2022, Jan 25; 109(2): 299-310.
  1. 6.   Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
  2. De Battista, Davide; Zamboni, Fausto; Gerstein, Hannah; Sato, Shinya; Markowitz,Tovah; Lack,Justin; Engle, Ronald E; Farci, Patrizia
  3. Journal of hepatocellular carcinoma. 2021, Nov 21; 8: 1399-1413.
  1. 7.   Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential
  2. O'Brien, Thomas R; Young,Howard; Donnelly, Raymond P; Prokunina-Olsson, Ludmila
  3. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2019, OCT 1; 39(10): 586-591.
  1. 8.   Nonhuman primate models of human viral infections
  2. Estes, Jake; Wong, Scott W.; Brenchley, Jason M.
  3. NATURE REVIEWS IMMUNOLOGY. 2018, Jun; 18(6): 390-404.
  1. 9.   Molecular Basis of Encapsidation of Hepatitis C Virus Genome
  2. Shi, Scarlett; Suzuki, Tetsuro
  3. Frontiers in Microbiology. 2018, Mar 07; 9: 396.
  1. 10.   Three-dimensional structure of the 3 ' X-tail of hepatitis C virus RNA in monomeric and dimeric states
  2. Cantero-Camacho, Angel; Fan, Lixin; Wang, Yun-Xing; Gallego, José
  3. RNA (New York, N.Y.). 2017, Sep 01; 23(9): 1465-1476.
  1. 11.   Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection
  2. Meissner, Eric G; Kohli, Anita; Higgins, Jeanette; Lee, Yu-Jin; Prokunina, Olga; Wu, David; Orr, Cody; Masur, Henry; Kottilil, Shyam
  3. Hepatology communications. 2017, Sep; 1(7): 586-594.
  1. 12.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 13.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 14.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 15.   IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection
  2. Martin, M. P.; Qi, Y.; Goedert, J. J.; Hussain, S. K.; Kirk, G. D.; Hoots, W. K.; Buchbinder, S.; Carrington, M.; Thio, C. L.
  3. Journal of Infectious Diseases. 2010, Dec; 202(11): 1749-1753.
  1. 16.   Crystal Structure of Human Interferon-lambda 1 in Complex with Its High-Affinity Receptor Interferon-lambda R1
  2. Miknis, Z. J.; Magracheva, E.; Li, W.; Zdanov, A.; Kotenko, S. V.; Wlodawer, A.
  3. Journal of Molecular Biology. 2010, Dec; 404(4): 650-664.
  1. 17.   High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection
  2. Ma, Z. M.; Stone, M.; Piatak, M.; Schweighardt, B.; Haigwood, N. L.; Montefiori, D.; Lifson, J. D.; Busch, M. P.; Miller, C. J.
  3. Journal of Virology. 2009 83(7): 3288-3297.
  1. 18.   Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
  2. O'Keefe, B. R.; Vojdani, F.; Buffa, V.; Shattock, R. J.; Montefiori, D. C.; Bakke, J.; Mirsalis, J.; d'Andrea, A. L.; Hume, S. D.; Bratcher, B.; Saucedo, C. J.; McMahon, J. B.; Pogue, G. P.; Palmer, K. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(15): 6099-6104.
  1. 19.   Protective HLA Class I Alleles That Restrict Acute-Phase CD8(+) T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1
  2. Wang, Y.; Li, B.; Carlson, J. M.; Streeck, H.; Gladden, A. D.; Goodman, R.; Schneidewind, A.; Power, K. A.; Toth, I.; Frahm, N.; Alter, G.; Brander, C.; Carrington, M.; Walker, B. D.; Altfeld, M.; Heckerman, D.; Allen, T. M.
  3. Journal of Virology. 2009 83(4): 1845-1855.
  1. 20.   Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid
  2. Yeung, M. L.; Bennasser, Y.; Watashi, K.; Le, S. Y.; Houzet, L.; Jeang, K. T.
  3. Nucleic Acids Research. 2009 37(19): 6575-6586.
  1. 21.   Statistical Resolution of Ambiguous HLA Typing Data
  2. Listgarten, J.; Brumme, Z.; Kadie, C.; Gao, X. J.; Walker, B.; Carrington, M.; Goulder, P.; Heckerman, D.
  3. Plos Computational Biology. 2008 4(2):
  1. 22.   IFN alpha and IFN lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity
  2. Maher, S. G.; Sheikh, F.; Scarzello, A. J.; Romero-Weaver, A. L.; Baker, D. P.; Donnelly, R. P.; Gamero, A. M.
  3. Cancer Biology & Therapy. 2008 7(7): 1109-1115.
  1. 23.   Seroprevalence and risk factors for human herpesvirus 8 infection, rural egypt
  2. Mbulaiteye, S. M.; Pfeiffer, R. M.; Dolan, B.; Tsang, V.; Noh, J.; Mikhail, N.; Abdel-Hamid, M.; Hashem, M.; Whitby, D.; Strickl, G. T.; Goedert, J. J.
  3. Emerging Infectious Diseases. 2008 14(4): 586-591.
  1. 24.   Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques
  2. Igarashi, T.; Iyengar, R.; Byrum, R. A.; Buckler-White, A.; Dewar, R. L.; Buckler, C. E.; Lane, H. C.; Kamada, K.; Adachi, A.; Martin, M. A.
  3. Journal of Virology. 2007, Oct; 81(20): 11549-11552.
  1. 25.   HIV/AIDS: in search of an animal model
  2. Ambrose, Z.; KewalRamani, V. N.; Bieniasz, P. D.; Hatziioannou, T.
  3. Trends in Biotechnology. 2007, Aug; 25(8): 333-337.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel